Pinpoint Therapeutics Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
- Investors
-
1
Pinpoint Therapeutics General Information
Description
Developer of novel autophagy inhibitor molecules designed to treat cancer. The company develops novel cancer treatment options aimed at specifically inhibiting autophagy, key cell survival, and treatment resistance pathways in cancer that target a recently discovered enzyme in the autophagy pathway, which is highly expressed across most cancers, enabling patients to overcome therapy resistance.
Contact Information
Website
www.pinpointtherapeutics.comCorporate Office
- 3401 Grays Ferry Avenue
- Building 176-1032
- Philadelphia, PA 19104
- United States
Corporate Office
- 3401 Grays Ferry Avenue
- Building 176-1032
- Philadelphia, PA 19104
- United States
Pinpoint Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 16-Sep-2025 | Completed | Out of Business | |||
| 3. Seed Round | 12-Dec-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2018 | Completed | Startup |
Pinpoint Therapeutics Comparisons
Industry
Financing
Details
Pinpoint Therapeutics Competitors (77)
One of Pinpoint Therapeutics’s 77 competitors is Apexian Pharmaceuticals, a Venture Capital-Backed company based in Indianapolis, IN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Apexian Pharmaceuticals | Venture Capital-Backed | Indianapolis, IN | ||||
| Cognition Therapeutics | Formerly VC-backed | New York, NY | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| ImmunOs Therapeutics | Venture Capital-Backed | Schlieren, Switzerland | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA |
Pinpoint Therapeutics Patents
Pinpoint Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-6699231-B1 | Methods and apparatus for perfusion of isolated tissue structure | Inactive | 31-Dec-1997 |
Pinpoint Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| University of Pennsylvania, Penn Engineering | University |
Pinpoint Therapeutics FAQs
-
When was Pinpoint Therapeutics founded?
Pinpoint Therapeutics was founded in 2018.
-
Where is Pinpoint Therapeutics headquartered?
Pinpoint Therapeutics is headquartered in Philadelphia, PA.
-
What industry is Pinpoint Therapeutics in?
Pinpoint Therapeutics’s primary industry is Drug Discovery.
-
Is Pinpoint Therapeutics a private or public company?
Pinpoint Therapeutics is a Private company.
-
What is Pinpoint Therapeutics’s current revenue?
The current revenue for Pinpoint Therapeutics is .
-
How much funding has Pinpoint Therapeutics raised over time?
Pinpoint Therapeutics has raised $1M.
-
Who are Pinpoint Therapeutics’s investors?
University of Pennsylvania, Penn Engineering has invested in Pinpoint Therapeutics.
-
Who are Pinpoint Therapeutics’s competitors?
Apexian Pharmaceuticals, Cognition Therapeutics, Inovio Pharmaceuticals, ImmunOs Therapeutics, and Kite Pharma are some of the 77 competitors of Pinpoint Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process